Professor, Medicine, UCSD School of Medicine
Infectious Disease
Dr. Francesca J. Torriani, MD
|
|
Give Review
Francesca J. Torriani practices Infectious Disease. She received 1 awards: "CMS Meaningful Use Stage 1 Certification". Francesca Torriani is also a published physician. She has 57 paper published. The most recent paper is: Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. She accepts Medicare payments and is registered with Medicare.gov.
Publications
- Severe Influenza in 33 US Hospitals, 2013-2014: Complications and Risk Factors for Death in 507 Patients.
- High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen.
- Genome of the pathogen Porphyromonas gingivalis recovered from a biofilm in a hospital sink using a high-throughput single-cell genomics platform.
- Discord among performance measures for central line-associated bloodstream infection.
- Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment.
- Sphingomonas paucimobilis bloodstream infections associated with contaminated intravenous fentanyl.
- Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection.
- Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis.
- Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults.
- Long-term results of treatment of macular complications in eyes with immune recovery uveitis using a graded treatment approach.
- Cardiovascular effects of antiretroviral therapy and noninvasive assessments of cardiovascular disease in HIV infection.
- Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection.
- Therapy and Prevention of Cytomegalovirus Retinitis.
- Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy.
- Lessons learned from the institution of the Surgical Care Improvement Project at a teaching medical center.
- Degree of viral decline early in treatment predicts sustained virological response in HCV-HIV coinfected patients treated with peginterferon alfa-2a and ribavirin.
- Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis.
- Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Cli...
- Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure.
- Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis...
- The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.
- A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087.
- Response to: ''carotid intima-media thickness: assessment of sub-clinical atherosclerosis in HIV-infected patients''.
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.
- Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection.
- Community-associated methicillin-resistant Staphylococcus aureus in the patient with HIV infection.
- Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic p...
- Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults.
- Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection.
- Pharmacodynamics of peginterferon alpha-2a and peginterferon alpha-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study.
- Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
- Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy.
- A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l.
- A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis.
- A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group...
- Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
- Pancreatic insuloma causing Cushing''s Syndrome.
- Autopsy findings in AIDS patients with Mycobacterium avium complex bacteremia.
- Uveitis associated with rifabutin prophylaxis.
- Disseminated Mycobacterium avium complex: correlation between blood and tissue burden.
- In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues.
- A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-base...
- Human immunodeficiency virus replication in AIDS patients with Mycobacterium avium complex bacteremia: a case control study. California Collaborative Treatment Group.
- Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to...
- Cidofovir in the treatment of cytomegalovirus (CMV) retinitis.
- Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.
- Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy.
- Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
- CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy.
- Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
- Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects.
- Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Rec...
- Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficienc...
- Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.
- Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral t...
- The Hepatitis C Cascade of Care among HIV Infected Patients: A Call to Address Ongoing Barriers to Care.
Conditions Treated
- Carpal Tunnel Syndrome
- Dupuytren's Contracture
- Osteoarthritis
- Rheumatoid Arthritis
Doctors Specialties
- Infectious Disease Medicine
- Orthopedic Hand Surgery
- Infectious Disease
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of California San Diego -
University of Lausanne Faculty of Medicine
Drug Facts
| NPI NUMBER | 1760440499 | |
| NPPES Provider LastName | TORRIANI | |
| NPPES Provider FirstName | FRANCESCA | |
| NPPES Provider ZIPCode | 921039000 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 179.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760440499 |
| Last Name Of The Provider | TORRIANI |
| First Name Of The Provider | FRANCESCA |
| View All |
Similar Doctors
|
|
Dr. Robert W. Ryder, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jonathan W. Jones, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodoros F. Katsivas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald B. Kearns, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew J. Meunier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary F. Bavaro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric P. Hofmeister, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shira Abeles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian T. Fitzgerald, MD |
|
|
Dr. Harold L. Groff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger A. Bitar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cathy L. Logan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John K. Chau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susannah Graves, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer M. Dan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Helen L. King, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheldon Lerner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Wyles, MD
This Doctor is OpenDoctor Recommended.
|